Caraci, Filippo

Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials

Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE

Fatty Acid Research and HealthTreatment of Major Depression

Cited by 449

β-Amyloid Monomers Are Neuroprotective

Giuffrida, M. L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Molinaro, G., Pappalardo, G., Messina, A., Palmigiano, A., et al. (2009) · The Journal of Neuroscience

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 421

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

Hampel, H., Caraci, F., Cuello, A. C., Caruso, G., Nisticò, R., Corbo, M., Baldacci, F., Toschi, N., Garaci, F., Chiesa, P. A., et al. (2020) · Frontiers in Immunology

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 360

Omega-3 fatty acids and depression: scientific evidence and biological mechanisms

Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014) · Oxidative Medicine and Cellular Longevity

Fatty Acid Research and HealthTryptophan and brain disorders

Cited by 351

Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target

Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research

Alzheimer's disease research and treatmentsTreatment of Major Depression

Cited by 172

Adherence to the Mediterranean Diet is Associated with Better Sleep Quality in Italian Adults

Godos, J., Ferri, R., Caraci, F., Cosentino, F. I. I., Castellano, S., Galvano, F., & Grosso, G. (2019) · Nutrients

Nutritional Studies and DietSleep and related disorders

Cited by 145

Polyphenols and neuroprotection: therapeutic implications for cognitive decline

Caruso, G., Torrisi, S. A., Mogavero, M. P., Currenti, W., Castellano, S., Godos, J., Ferri, R., Galvano, F., Leggio, G. M., Grosso, G., et al. (2022) · Pharmacology & Therapeutics

Phytochemicals and Antioxidant ActivitiesDementia and Cognitive Impairment Research

Cited by 140

Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders

Caruso, G., Caraci, F., & Jolivet, R. B. (2019) · Progress in Neurobiology

Biochemical effects in animalsAlzheimer's disease research and treatments

Cited by 110

Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?

Spampinato, S. F., Copani, A., Nicoletti, F., Sortino, M. A., & Caraci, F. (2018) · Frontiers in Molecular Neuroscience

Neuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 105

Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells

Caruso, A., Motolese, M., Iacovelli, L., Caraci, F., Copani, A., Nicoletti, F., Terstappen, G. C., Gaviraghi, G., & Caricasole, A. (2006) · Journal of Neurochemistry

Wnt/β-catenin signaling in development and cancerAlzheimer's disease research and treatments

Cited by 101

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation

Iulita, M. F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., Cantarella, R. A., Elia, F., Buono, S., Recupero, M., et al. (2016) · Alzheimer's & Dementia

Down syndrome and intellectual disability researchDementia and Cognitive Impairment Research

Cited by 99

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Lista, S., Imbimbo, B. P., Grasso, M., Fidilio, A., Emanuele, E., Minoretti, P., López-Ortiz, S., Martín-Hernández, J., Gabelle, A., Caruso, G., et al. (2024) · Journal of Neuroinflammation

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 81

TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

Caraci, F., Battaglia, G., Busceti, C., Biagioni, F., Mastroiacovo, F., Bosco, P., Drago, F., Nicoletti, F., Sortino, M. A., & Copani, A. (2008) · Neurobiology of Disease

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 79

The Many Faces of Mitochondrial Dysfunction in Depression: From Pathology to Treatment

Caruso, G., Benatti, C., Blom, J. M. C., Caraci, F., & Tascedda, F. (2019) · Frontiers in Pharmacology

Treatment of Major DepressionMitochondrial Function and Pathology

Cited by 65

Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons

Giuffrida, M. L., Tomasello, M. F., Pandini, G., Caraci, F., Battaglia, G., Busceti, C., Di Pietro, P., Pappalardo, G., Attanasio, F., Chiechio, S., et al. (2015) · Frontiers in Cellular Neuroscience

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 52

Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease

Caraci, F., Nicoletti, F., & Copani, A. (2018) · Current Opinion in Pharmacology

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 37

The lifetime prevalence and impact of generalized anxiety disorders in an epidemiologic Italian National Survey carried out by clinicians by means of semi-structured interviews

Preti, A., Demontis, R., Cossu, G., Kalcev, G., Cabras, F., Moro, M. F., Romano, F., Balestrieri, M., Caraci, F., Dell’Osso, L., et al. (2021) · BMC Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 31

Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors improve cognitive function in partial responders depressed patients: Results from a prospective observational cohort study

Castellano, S., Ventimiglia, A., Salomone, S., Ventimiglia, A., Vivo, S., Signorelli, M., Bellelli, E., Santagati, M., Cantarella, R., Fazio, E., et al. (2016) · CNS & Neurological Disorders - Drug Targets

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 31

The Prevalence of Specific Phobia by Age in an Italian Nationwide Survey: How Much Does it Affect the Quality of Life?

Sancassiani, F., Romano, F., Balestrieri, M., Caraci, F., Di Sciascio, G., Drago, F., Hardoy, M. C., Moro, M. F., Roncone, R., Piras, M., et al. (2019) · Clinical Practice & Epidemiology in Mental Health

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 24

Chronotype and Cancer: Emerging Relation Between Chrononutrition and Oncology from Human Studies

Godos, J., Currenti, W., Ferri, R., Lanza, G., Caraci, F., Frias-Toral, E., Guglielmetti, M., Ferraris, C., Lipari, V., Carvajal Altamiranda, S., et al. (2025) · Nutrients

Dietary Effects on HealthCircadian rhythm and melatonin

Cited by 22

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology

Alzheimer's disease research and treatmentsDown syndrome and intellectual disability research

Cited by 18

The role of venlafaxine in the modern treatment of anxiety disorders: a critical update and expert clinical perspectives

Fagiolini, A., Bondi, E., Caraci, F., Camardese, G., Dell’Osso, B., Percudani, M., Sani, G., & Fiorillo, A. (2026) · Rivista di psichiatria

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 0